Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Trading Statement

18 Jan 2023 07:00

RNS Number : 0212N
Galliford Try Holdings PLC
18 January 2023
 

Galliford Try Holdings plc

Trading Update

18 January 2023

 

 

Galliford Try Holdings plc, the UK construction group, today provides an update on trading for the half year period from 1 July 2022 to 31 December 2022. The Group expects to announce its results for the half year on 8 March 2023.

 

 

Update on Current Trading

 

The Group is performing well with trading in line with the Board's expectations. We are well placed for the financial year to 30 June 2023 and continue to make good progress against our Sustainable Growth Strategy.

 

We continue to maintain good relationships with our supply chain and clients which, together with our strong balance sheet, has enabled us to manage the economic conditions effectively with no material impact on trading.

 

Capitalising on our financial strength we are pleased with our two recent acquisitions, of MCS Control Systems and Ham Baker, in the first half of the year and the integration and development of these businesses into our Environment division is progressing as planned.

 

Balance Sheet

 

The average month-end cash for the six months ended 31 December 2022 was circa £154m (year to 30 June 2022: £174m) and period-end cash at 31 December 2022 was circa £195m (31 December 2021: £211m). This is in line with the Board's expectations given the recent acquisitions, our ongoing investment in cloud-based digital systems as previously disclosed, and circa £10m of dividends and capital returns in the half year. The Group maintains a portfolio of PPP assets and has no pensions liabilities and no debt or associated covenants.  

 

The Group's strong balance sheet supports our ability to continue to secure high quality contracts and frameworks.

 

Order Book and Outlook

 

The Group's order book of £3.5bn provides good visibility of future workload. We continue to see a robust pipeline of new opportunities across our chosen sectors, supported by our strong track record and focus on the public and regulated sectors alongside high-quality private clients.

 

Recent framework and project wins include the £95m Rye Hill custodial facility for the Ministry of Justice, a £65m manufacturing facility for JDR Cable Systems and two frameworks for Welsh Water, representing the first capital maintenance framework wins for the business since the acquisition of nmcn water.

 

Capital Allocation

 

In September 2022, having reviewed the Group's strong cash performance and ongoing capital requirements while continuing to prioritise a strong balance sheet, the Group launched a share buyback programme of up to a maximum of £15m company shares. As at 16 January 2023 the Group has purchased a total of 2,489,671 shares, for an aggregate consideration of £3.9m.

 

Board

 

After over seven years on the board Gavin Slark, Non-executive Director, has decided to step down from the board on 31 March 2023, due to other business commitments.

 

Bill Hocking, Chief Executive, commented:

 

"Performance in the first half of the financial year has demonstrated good progress against our strategic objectives and provides confidence for the full year.

 

We are pleased with our recent acquisition of MCS Control Systems and Ham Baker, complementing our existing operations and affording an enhanced specialist service to our water sector and related clients. 

 

We have excellent people and project teams, a strong balance sheet and high-quality order book in our chosen sectors. We have confidence in our ability to deliver our strategy and long-term sustainable value for all stakeholders."

 

A conference call for Analysts and Investors will be held at 09:00am BST today, Wednesday 18 January 2023.

 

Dial-in: +44 800 640 6441(Toll Free) or +44 20 3936 2999.

 

Access code: 794330

 

For further enquiries please contact:

 

Galliford Try

Bill Hocking, Chief Executive

Andrew Duxbury, Finance Director

Kevin Corbett, General Counsel & Company Secretary

01895 855001

Tulchan Communications

James Macey White

 

 

020 7353 4200

 

Note to Editors

Galliford Try is a trading name of Galliford Try Holdings plc, a leading UK construction group listed on the London Stock Exchange. Operating as Galliford Try and Morrison Construction, the group carries out building and infrastructure (environment and highways) projects with clients in the public, private and regulated sectors across the UK.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBSGDBXXBDGXR
Date   Source Headline
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSContract
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
6th Oct 202512:00 pmRNSAnnual Financial Report
1st Oct 202510:00 amRNSTotal Voting Rights
30th Sep 20254:00 pmRNSHolding(s) in Company
29th Sep 20254:26 pmRNSDirector/PDMR Shareholding
26th Sep 20256:00 pmRNSFidelity European Trust
25th Sep 20253:57 pmRNSDirector/PDMR Shareholding - Replacement
25th Sep 20253:37 pmRNSDirector/PDMR Shareholding - Replacement
25th Sep 20253:00 pmRNSDirector/PDMR Shareholding
25th Sep 20253:00 pmRNSDirector/PDMR Shareholding
25th Sep 20253:00 pmRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20255:00 pmRNSHolding(s) in Company
18th Sep 20255:00 pmRNSHolding(s) in Company
17th Sep 20257:02 amRNSLaunch of Share Buyback Programme
17th Sep 20257:00 amRNSFinal Results
11th Sep 20255:00 pmRNSHolding(s) in Company
9th Sep 20254:15 pmRNSHolding(s) in Company
9th Sep 20253:05 pmRNSHolding(s) in Company
1st Sep 202510:00 amRNSTotal Voting Rights
28th Aug 20253:48 pmRNSHolding(s) in Company
26th Aug 20251:00 pmRNSBlock listing Interim Review
21st Aug 202510:15 amRNSContract
1st Aug 202510:00 amRNSTotal Voting Rights
9th Jul 20257:00 amRNSTrading Statement
1st Jul 20253:00 pmRNSHolding(s) in Company
30th Jun 20254:00 pmRNSTotal Voting Rights
18th Jun 20253:00 pmRNSDirector/PDMR Shareholding
2nd Jun 20257:00 amRNSTotal Voting Rights
21st May 20257:10 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20254:00 pmRNSDirector/PDMR Shareholding
19th May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
1st May 202510:00 amRNSTotal Voting Rights
30th Apr 20257:00 amRNSTransaction in Own Shares
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.